Case of a Girl with Lower Abdominal Pain

  • Megan Jacobs
  • Paritosh Kaul


The chapter aims to review differential diagnoses of an adolescent female with abdominal pain. It will examine risk factors in the adolescent to diagnose and treat different etiologies of abdominal and pelvic pain. Pregnancy, sexually transmitted infections, and long-term fertility preservation are vital components in these evaluations. Pelvic inflammatory disease is a clinical diagnosis of exclusion and requires a low threshold for treatment. CDC diagnostic and treatment guidelines in this population will be reviewed, as well as recommendations for follow-up. Providing comprehensive care including addressing issues of confidentiality and access to healthcare services will allow providers to impact long-term outcomes among youth.


Pelvic inflammatory disease (PID) Cervical motion tenderness (CMT) Pelvic pain Abdominal pain Adolescent Sexually transmitted infections Bacterial vaginosis Intrauterine device (IUD) 


  1. 1.
    MMWR Recomm Rep. 2015;64(3):1–82.Google Scholar
  2. 2.
    Shulman LP, Nelson AL, Darney PD. Recent developments in hormone delivery systems. Am J Obset Gynecol. 2004;190(4 Suppl):S39–48.CrossRefGoogle Scholar
  3. 3.
    Moore SG, et al. Clinical utility of measuring white blood cells on vaginal wet mount and endocervical gram stain for the prediction of chlamydial and gonococcal infections. Sex Transm Dis. 2000;27(9):530–8.CrossRefGoogle Scholar
  4. 4.
    British Columbia Treatment Guidelines: Sexually Transmitted Infections in Adolescents and Adults (2014) Section 4.Google Scholar
  5. 5.
    Sweet RL. Treatment of acute pelvic inflammatory disease. Infect Dis Obstet Gynecol. 2011;2011:561909. Scholar
  6. 6.
    The American College of Obstetricians and Gynecologists, Committee Opinion Number 539, October 2012, reaffirmed 2014.Google Scholar
  7. 7.
    Committee on Adolescence. Contraception for adolescents. Pediatrics. 2014.
  8. 8.
    Toivonen J, Luukkainen T, Allonen H. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years’ comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet Gynecol. 1991;77:261–4.CrossRefGoogle Scholar
  9. 9.
    Kaul P, Stevens-Simon C, Saproo A, Coupey SM. Trends in illness severity and length of stay in inner-city adolescents hospitalized for pelvic inflammatory disease. J Pediatr Adolesc Gynecol. 2008;21:289–93.CrossRefGoogle Scholar
  10. 10.
    Weström L, et al. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis. 1992;19(4):185–92.CrossRefGoogle Scholar
  11. 11.
    United States Census Bureau. Current Population Survey (CPS). Fertility; 2012.Google Scholar
  12. 12.
    Short V, et al. Clinical presentation of Mycoplasma genitalium infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis. 2009;48(1):41–7. Scholar
  13. 13.
    Abu Raya B, et al. Beyond “safe sex”—can we fight adolescent pelvic inflammatory disease? Eur J Pediatr. 2013;172(5):581–90.CrossRefGoogle Scholar
  14. 14.
    Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40:187–93.CrossRefGoogle Scholar
  15. 15.
    Burnett AM, Anderson CP, Zwank MD. Laboratory-confirmed gonorrhea and/or chlamydia rates in clinically diagnosed pelvic inflammatory disease and cervicitis. Am J Emerg Med. 2012;30:1114–7.CrossRefGoogle Scholar
  16. 16.
    Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;334:1362–6.CrossRefGoogle Scholar
  17. 17.
    Cohen CR, Manhart LE, Bukusi EA, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet. 2002;359:765–6.CrossRefGoogle Scholar
  18. 18.
    Cohen CR, Mugo NR, Astete SG, et al. Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect. 2005;81:463–6.CrossRefGoogle Scholar
  19. 19.
    Ross JD, Cronje HS, Paszkowski T, et al. Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. Sex Transm Infect. 2006;82:446–51.CrossRefGoogle Scholar
  20. 20.
    Mena LA, Mroczkowski TF, Nsuami M, et al. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis. 2009;48:1649–54.CrossRefGoogle Scholar
  21. 21.
    Schwebke JR, Rompalo A, Taylor S, et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens—a randomized clinical trial. Clin Infect Dis. 2011;52:163–70.CrossRefGoogle Scholar
  22. 22.
    Warner L, et al. Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis. 2006;33(1):36–51.CrossRefGoogle Scholar

ACOG committee opinion statements:

  1. 1.
    Number 539, October 2012 Adolescents and Long-Acting Reversible Contraception: Implant Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices Google Scholar
  2. 2.
    Number 672, September 2016 Clinical Challenges Of Long-Acting Reversible Contraceptive Methods Google Scholar
  3. 3.
    Number 626, March 2015 The Transition from Pediatric to Adult Health Care: Preventative Care for Young Women Aged 18–26 Years Google Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Section of Adolescent Medicine, Department of PediatricsUniversity of Colorado – School of Medicine, Children’s Hospital ColoradoAuroraUSA

Personalised recommendations